Trexquant Investment LP Acadia Pharmaceuticals Inc Transaction History

Trexquant Investment LP

$8.35 Billion
Q2 2025

A detailed history of Trexquant Investment LP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Trexquant Investment LP holds 509,949 shares of ACAD stock, worth $10.7 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

509,949

Previous 294,297 73.28%

Holding current value

$10.7 Million

Previous $4.89 Million 125.02%

% of portfolio

0.13%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$14.1 - $22.95 $3.04 Million - $4.95 Million	215,652 Added 73.28%	509,949 $11 Million
Q1 2025 May 14, 2025	SELL	$16.61 - $20.29 $2.31 Million - $2.82 Million	-138,858 Reduced 32.06%	294,297 $4.89 Million
Q4 2024 Feb 12, 2025	BUY	$14.29 - $18.76 $702,582 - $922,354	49,166 Added 12.8%	433,155 $7.95 Million
Q3 2024 Nov 12, 2024	BUY	$15.14 - $19.14 $1.25 Million - $1.58 Million	82,311 Added 27.28%	383,989 $5.91 Million
Q2 2024 Aug 13, 2024	SELL	$14.62 - $18.42 $553,118 - $696,883	-37,833 Reduced 11.14%	301,678 $4.9 Million
Q1 2024 May 14, 2024	BUY	$17.79 - $30.86 $5.29 Million - $9.18 Million	297,367 Added 705.6%	339,511 $6.28 Million
Q4 2023 Feb 09, 2024	BUY	$20.78 - $31.77 $875,752 - $1.34 Million	42,144 New	42,144 $1.32 Million
Q2 2023 Aug 11, 2023	BUY	$17.8 - $25.65 $852,388 - $1.23 Million	47,887 Added 43.85%	157,084 $3.76 Million
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $137,234 - $175,916	8,409 Added 8.34%	109,197 $2.06 Million
Q4 2022 Feb 13, 2023	BUY	$14.2 - $18.63 $755,553 - $991,265	53,208 Added 111.83%	100,788 $1.6 Million
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $671,353 - $869,286	47,580 New	47,580 $778,000
Q2 2022 Aug 11, 2022	SELL	$13.01 - $27.22 $1.28 Million - $2.68 Million	-98,612 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$20.94 - $27.5 $2.06 Million - $2.71 Million	98,612 New	98,612 $2.39 Million
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $401,314 - $647,505	-23,902 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$15.78 - $24.77 $248,250 - $389,681	-15,732 Reduced 39.69%	23,902 $397,000
Q2 2021 Aug 12, 2021	BUY	$19.4 - $27.42 $768,899 - $1.09 Million	39,634 New	39,634 $967,000
Q1 2021 May 13, 2021	SELL	$25.02 - $54.99 $595,400 - $1.31 Million	-23,797 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$41.04 - $56.79 $227,854 - $315,298	5,552 Added 30.43%	23,797 $1.27 Million
Q3 2020 Nov 06, 2020	BUY	$36.42 - $57.0 $112,064 - $175,389	3,077 Added 20.29%	18,245 $753,000
Q2 2020 Aug 07, 2020	SELL	$39.26 - $52.73 $99,249 - $133,301	-2,528 Reduced 14.29%	15,168 $735,000
Q1 2020 May 08, 2020	SELL	$31.65 - $46.87 $2.36 Million - $3.5 Million	-74,645 Reduced 80.84%	17,696 $748,000
Q4 2019 Feb 12, 2020	BUY	$36.21 - $51.4 $2.46 Million - $3.49 Million	67,844 Added 276.95%	92,341 $3.95 Million
Q3 2019 Nov 08, 2019	BUY	$22.22 - $44.01 $16,465 - $32,611	741 Added 3.12%	24,497 $882,000
Q2 2019 Aug 09, 2019	SELL	$23.32 - $28.12 $151,136 - $182,245	-6,481 Reduced 21.43%	23,756 $635,000
Q1 2019 May 13, 2019	SELL	$16.17 - $27.38 $170,140 - $288,092	-10,522 Reduced 25.82%	30,237 $812,000
Q4 2018 Feb 13, 2019	BUY	$14.32 - $22.92 $583,668 - $934,196	40,759 New	40,759 $659,000
Q3 2018 Nov 09, 2018	SELL	$13.03 - $21.81 $368,501 - $616,808	-28,281 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$15.07 - $22.34 $356,390 - $528,318	-23,649 Reduced 45.54%	28,281 $432,000
Q1 2018 May 03, 2018	BUY	$22.47 - $32.33 $1.17 Million - $1.68 Million	51,930 New	51,930 $1.17 Million

Others Institutions Holding ACAD

# of Institutions

348

Shares Held

163M

Call Options Held

811K

Put Options Held

334K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Acadia Pharmaceuticals Inc Transaction History